BCX-1777

BCX-1777 · BioCryst Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BCX-1777, covering 2013-05-30 to 2013-05-30. Get the full timeline:

Most recent: Clinical Trial Update: BCX-1777 in Treating Patients With Refractory Cutaneous T-Cell Lymphoma [Phase 1, Phase 2]